Open access
Aug 2026
Tissue-specific untargeted 1H-NMR metabolomics reveals no adverse metabolic effects of daily intrabuccal cannabidiol (CBD) in healthy mice
The results suggest a more metabolically balanced state in the mice, and support the adjunctive use of CBD, as no adverse metabolic effects were observed in the brain, liver, or kidneys.
M. V. Masiphephethu, S. Bhengu, K. Venter et al.
· Frontiers in Pharmacology · 0 citations